Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 3 days agoIt’s important to note that the vaccine maker, which employs about 5,100 people as of June 2023 and...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 3 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
BioPharma Dive via Yahoo Finance· 6 days agoLarge and small drugmakers are vying for a piece of what analysts view as one of the biggest market...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 5 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 3 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter revenue is down ...
Biotech’s bind over China bill
Politico· 2 days agoBancel suggested the shot’s presentation — a pre-filled syringe — could be a game-changing differentiator for busy health care providers. GSK and Pfizer make RSV vaccines ...
Optimized Hospital Care Improves Gout Treatment Uptake
Medscape· 7 days agoOptimizing how people experiencing a gout flare are managed in hospital and then followed-up afterwards can substantially increase the uptake of guideline-recommended urate-lowering therapy ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 3 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.